City GPS observatory looks at senolytics technology as a 2018 disruptive innovation that is already here to stay:
"Many biotech companies, including Unity Biotechnology and Calico (a Google venture), are developing therapies with the goal of extending the human healthspan — defined as the portion of life lived free of age-related disease. These companies are exploring a number of potentially transformative approaches, including circulating youth factors, mitochondrial dysfunction, and the elimination of a specific cell type called ‘senescent cells.’ In our view, targeting these so-called senescent cells, which are believed to be the drivers of numerous age-related diseases, appears to be the most promising anti-aging approach explored thus far".
Go to this .pdf's page 18 here: https://www.citibank...ovations_VI.pdf
